We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis.
- Authors
Xu, Junying; Yang, Xuejing; Mao, Yong; Mei, Jie; Wang, Huiyu; Ding, Junli; Hua, Dong
- Abstract
In recent years, immunotherapies have emerged as effective therapeutic strategies for treating human cancers. However, accumulating evidence has revealed an inconsistency between the response to immune checkpoint inhibitors and programmed death ligand 1 (PD-L1) expression status detected by immunohistochemistry staining. Recent research has revealed that the removal of N-Linked glycosylation significantly enhanced PD-L1 detection, resulting in both more accurate PD-L1 quantification and clinical outcome prediction. In the present study, we evaluated natural and deglycosylated PD-L1 expression in colon cancer using the PD-L1 28–8 antibody. The results of the present study validated the hypothesis that PD-L1 had a higher expression in colon cancer tissues compared with normal tissues. Additionally, colon tumors with defective mismatch repair tended to express higher PD-L1 than those without. Most importantly, the results of the present study indicated that the removal of N-linked glycosylation remarkably enhanced PD-L1 detection. Moreover, the PD-L1 signal intensity of samples with a low natural PD-L1 signal was enhanced more remarkably than that of samples with high signal intensity. Overall, our research provides an improved strategy for patient stratification for anti-PD-1/PD-L1 therapy, which deepens the clinical significance of this established strategy for treatment of colon cancer.
- Subjects
GLYCOSYLATION; COLON cancer; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IMMUNE checkpoint inhibitors
- Publication
Technology in Cancer Research & Treatment, 2021, p1
- ISSN
1533-0346
- Publication type
Article
- DOI
10.1177/15330338211019442